Bonnert Marianne, Särnholm Josefin, Andersson Erik, Bergström Sten-Erik, Lalouni Maria, Lundholm Cecilia, Serlachius Eva, Almqvist Catarina
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Sweden, Nobels väg 12, 171 77 Stockholm, Sweden.
Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Sweden, Norra Stationsgatan 69, 113 64 Stockholm, Sweden.
Internet Interv. 2021 Jun 17;25:100415. doi: 10.1016/j.invent.2021.100415. eCollection 2021 Sep.
There is an established relationship between anxiety and asthma, which is associated with poor health outcomes. Most previous cognitive behavior therapies (CBT) have focused on comorbid panic disorder whereas anxiety related to asthma may rather be illness-specific. The feasibility of an online CBT targeting avoidance behavior in anxiety related to asthma was evaluated, using a pretest-posttest design. Thirty participants with self-reported anxiety related to asthma were offered an eight-week treatment with therapist support. Mean adherence was good (80% of content), and most participants (89%) reported adequate relief after treatment. Catastrophizing about asthma (CAS), assessed at 2 months after treatment, improved significantly with a large effect size (Cohen's = 1.52). All secondary outcomes, including asthma control, avoidance behavior, fear of asthma symptoms and quality of life, improved significantly with moderate to large effect sizes (: 0.40-1.44). All improvements were stable at 4 months follow up. Weekly ratings showed that a decrease in avoidance behavior predicted a decrease in CAS the following week throughout the treatment period. We conclude that CBT targeting avoidance behavior is a feasible treatment for anxiety related to asthma. The results justify investigation of efficacy and mechanisms of change in a randomized controlled trial. ClinicalTrials.gov, ID: NCT03486756.
焦虑与哮喘之间存在既定的关联,这与不良健康结果相关。以往大多数认知行为疗法(CBT)都侧重于共病惊恐障碍,而与哮喘相关的焦虑可能更具疾病特异性。采用前后测试设计,评估了一种针对哮喘相关焦虑中回避行为的在线CBT的可行性。30名自我报告有哮喘相关焦虑的参与者接受了为期八周的治疗,并得到治疗师的支持。平均依从性良好(80%的内容),大多数参与者(89%)报告治疗后有足够的缓解。在治疗后2个月评估的哮喘灾难化思维(CAS)有显著改善,效应量较大(科恩d值=1.52)。所有次要结局,包括哮喘控制、回避行为、对哮喘症状的恐惧和生活质量,均有显著改善,效应量为中度至较大(d值:0.40 - 1.44)。所有改善在随访4个月时均保持稳定。每周评分显示,在整个治疗期间,回避行为的减少预示着下周CAS的减少。我们得出结论,针对回避行为的CBT是治疗哮喘相关焦虑的一种可行疗法。这些结果证明在随机对照试验中研究其疗效和改变机制是合理的。ClinicalTrials.gov标识符:NCT03486756。